NCT03378830
- Conditions
- Adenotonsillectomy, Apnea, Dyssomnias, +23 more
- Locations
-
- The Montreal Children's Hospital Montreal, Quebec, Canada
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,082 public trials
2,050 recruiting studies
Lymphoproliferative Disorders trial results
Completed
Risk Stratification of Nodal PTCL
NCT03040206
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Chonbuk Nationla University Hospital Jeonju, South Korea
NCT01448096
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Chonbuk National University Hospital Jeonju, South Korea
Completed
Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma
NCT00932698
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Emory University Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Conditions
- B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, +15 more
- Locations
-
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Children's Hospital and Research Center at Oakland Oakland, California, United States
- Childrens Hospital of Orange County Orange, California, United States
Completed
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01839916
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University "Mother Theresa" Hospital Center; Oncology Department Tirana, Albania
- CEMIC Saavedra Buenos Aires, Argentina
- Instituto Damic Córdoba, Argentina
- Hospital Privado de Comunidad; Oncology Mar del Plata, Argentina
NCT00004228
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Southern California Permanente Medical Group Downey, California, United States
Completed
Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma
NCT01162551
- Conditions
- Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT02389101
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
- Locations
-
- Turku University Hospital Turku, Finland